111
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of Xenopus tropicalis as an Alternative Test Organism for Frog Embryo Teratogenesis Assay—Xenopus (FETAX)

, , , , , , & show all
Pages 177-189 | Published online: 14 Jul 2003

References

  • Gurdon J.B. Introductory comments: Xenopus as a laboratory animal. The Biology of Xenopus, R.C. Tinsley, H.R. Kobel. Oxford University Press Inc., New York 1996; 3–6
  • Amaya E., Offield M.F., Grainger R.M. Frog genetics: Xenopus tropicalis jumps into the future. Trends Genet. 1998; 14: 253–255
  • Dawson D.A., Fort D.J., Newell D.L., Bantle J.A. Developmental toxicity testing with FETAX: evaluation of five compounds. Drug Chem. Toxicol. 1989; 12: 67–75
  • Dresser T.H., Rivera E.R., Hoffmann F.J., Finch R.A. Teratogenic assessment of four solvents using the frog embryo teratogenesis assay—Xenopus (FETAX). J. Appl. Toxicol. 1992; 12: 49–56
  • Fort D.J., Bantle J.A. Analysis of the mechanism of isoniazid-induced developmental toxicity with frog embryo teratogenesis assay: Xenopus (FETAX). Teratogen Carcinogen Mutagen 1990; 10: 463–476
  • Fort D.J., James B.L., Bantle J.A. Evaluation of the developmental toxicity of five compounds with the frog embryo teratogenesis assay: Xenopus (FETAX) and a metabolic activation system. J. Appl. Toxicol. 1989; 9: 377–388
  • Fort D.J., Propst T.L., Stover E.L. Evaluation of the developmental toxicity of 4-bromobenzene using frog embryo teratogenesis assay—Xenopus: possible mechanisms of action. Teratogen Carcinogen Mutagen 1996; 16: 307–315
  • Morgan M.K., Scheuerman P.R., Bishop C.S., Pyles R.A. Teratogenic potential of atrazine and 2,4-D using FETAX. J. Toxicol. Environ. Health 1996; 48: 151–168
  • Sunderman F.W., Jr., Plowman M.C., Hopfer S.M. Embryotoxicity and teratogenicity of cadmium chloride in Xenopus laevis, assayed by the FETAX procedure. Ann. Clin. Lab. Sci. 1991; 21: 381–391
  • Dumont J.N., Schultz T.W., Buchanan M., Kai G. Frog Embryo Teratogenesis Assay: Xenopus—A Short-Term Assay Applicable to Complex Mixtures. Symposium on the Application of Short-Term Bioassays in the Analysis of Complex Mixtures III, M.D. Waters, S.S. Sandhu, J. Lewtas, L. Claxton, N. Chernoff, S. Nesnow. Plenum, New YorkNY, USA 1983; 393–405
  • American Society for Testing and Materials. Standard guide for conducting the frog embryo teratogenesis assay—Xenopus (FETAX). Annual Book of ASTM Standards. Philadelphia, PA 1998; Vol. 11.05: 826–836
  • Bantle J.A., Burton D.T., Dawson D.A., Dumont J.N., Finch R.A., Fort D.J., Linder G., Rayburn J.R., Buchwalter D., Maurice M.A. Initial interlaboratory validation study of FETAX: phase I testing. J. Appl. Toxicol. 1994; 14: 213–223
  • Bantle J.A., Finch R.A., Burton D.T., Fort D.J., Dawson D.A., Linder G., Rayburn Jr., Hull M., Kumsher-King M., Gaudet-Hull A.M., Turley S.D. FETAX interlaboratory validation study: phase III-Part 1 testing. J. Appl. Toxicol. 1996; 16: 517–528
  • Bantle J.A., Fort D.J., Rayburn J.R., DeYoung D.J., Bush S.J. Further validation of FETAX: evaluation of the developmental toxicity of five known mammalian teratogens and non-teratogens. Drug Chem. Toxicol. 1990; 13: 267–282
  • Burkhart J.G., Helgen J.C., Fort D.J., Gallagher K., Bowers D., Propst T.L., Gernes M., Magner J., Shelby M.D., Lucier G. Induction of mortality and malformation in Xenopus laevis embryos by water sources associated with field frog deformities. Environ. Health Perspect. 1998; 106: 841–848
  • Fort D.J., Rayburn Jr., Bantle J.A. Evaluation of acetaminophen-induced developmental toxicity using FETAX. Drug Chem. Toxicol. 1992; 15: 329–350
  • Fort D.J., Rogers R.L., Bruning L.A., Stover E.L., Helgen J.C., Burkhart J.G. Progress toward identifying causes of mal-development induced in Xenopus by pond water and sediment extracts from Minnesota, USA. Environ. Toxicol. Chem. 1999; 18: 2316–2324
  • Fort D.J., Rogers R.L., Paul R.R., Miller M.F., Clark P., Stover E.L., Yoshioko J., Quimby F., Sower S.A., Reed K.L., Babbitt K.J., Rolland R. Effects of pond water, sediment and sediment extract samples from New Hampshire, USA on early Xenopus development and metamorphosis: comparison to native species. J. Appl. Toxicol. 2001; 21: 199–209
  • Fort D.J., Stover E.L., Farmer D.R., Lemen J.K. Assessing the predictive validity of frog embryo teratogenesis assay—Xenopus (FETAX). Teratogen Carcinogen Mutagen 2000; 20: 87–98
  • Fort D.J., Stover E.L., Norton D. Ecological hazard assessment of aqueous soil extracts using FETAX. Frog Embryo Teratogenesis Assay-Xenopus. J. Appl. Toxicol. 1995; 15: 183–191
  • Barinaga M. Where have all the froggies gone?. Science 1990; 247: 1033–1034
  • Berger L., Speare R., Daszak P., Green D.E., Cunningham A.A., Goggin C.L., Slocombe R., Ragan M.A., Hyatt A.D., McDonald K.R., Hines H.B., Lips K.R., Marantelli G., Parkes H. Chytridiomycosis causes amphibian mortality associated with population declines in the rain forests of Australia and Central America. Proc. Natl. Acad. Sci. 1998; 95: 9031–9036
  • Carey C. Infectious disease and worldwide declines of amphibian populations, with comments on emerging diseases in coral reef organisms and in humans. Environ. Health Perspect. 2000; 108(suppl. 1))1, 143–150
  • Carey C., Cohen N., Rollins-Smith L. Amphibian declines: an immunological perspective. Dev. Comp. Immunol. 1999; 23: 459–472
  • Morell V. Are pathogens felling frogs?. Science 1999; 284: 728–731
  • Fort D.J., Stover E.L., Bantle J.A., Finch R.A. Evaluation of the developmental toxicity of thalidomide using frog embryo teratogenesis assay—Xenopus (FETAX): biotransformation and detoxification. Teratogen Carcinogen Mutagen 2000; 20: 35–47
  • Fort D.J., Stover E.L., Propst T., Hull M.A., Bantle J.A. Evaluation of the developmental toxicity of theophylline, dimethyluric acid, and methylxanthine metabolites using Xenopus. Drug Chem. Toxicol. 1996; 19: 267–278
  • Fort D.J., Stover E.L., Rayburn Jr., Hull M., Bantle J.A. Evaluation of the developmental toxicity of trichloroethylene and detoxification metabolites using Xenopus. Teratogen Carcinogen Mutagen 1993; 13: 35–45
  • Propst T.L., Fort D.J., Stover E.L., Schrock B., Bantle J.A. Evaluation of the developmental toxicity of benzo[a]pyrene and 2-acetylaminofluorene using Xenopus: modes of biotransformation. Stover Group Drug Chem. Toxicol. 1997; 20: 45–61
  • Grainger R.M. Bringing Genetics to Xenopus: Half the Genome, Twice as Fast. 2001; Vol. 2001
  • Dawson D.A., Bantle J.A. Development of a reconstituted water medium and initial validation of FETAX. J. Appl. Toxicol. 1987; 7: 237–244
  • Nieuwkoop P.D., Faber J. Normal Tables of Xenopus laevis (Daudin). Garland Publishing, Inc., New York 1975
  • Bantle J.A., Dumont J.N., Finch R.A., Linder G., Fort D.J. Atlas of Abnormalities: A Guide for the Performance of FETAX. 2nd Ed. Oklahoma State University, Stillwater, OKUSA 1998
  • Hamilton M., Russo R.C., Thurston R.V. Trimmed Spearman–Karber method for estimating median lethal concentrations in toxicity bioassays. Environ. Sci. Technol. 1978; 12: 417
  • Fort D.J., McLaughlin D.W., Rogers R.L., Buzzard B.O., Thomas J.H., Burkhart J.G. The comparative sensitivity of Xenopus tropicalis as an alternative test species for the FETAX model. Environ. Toxicol. Chem., in press

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.